Caveolin scaffolding region and cholesterol-rich domains in membranes

Journal of Molecular Biology

Volumn 345, Issue 2, 2005, Pages 339-350

  Epand, Richard M ^a,b   Sayer, Brian G ^b   Epand, Raquel F ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

caveolae; cholesterol rich domain; MAS NMR; peptide lipid interactions

Indexed keywords

AMINO ACID; CAVEOLIN 1; CHOLESTEROL; PHOSPHATIDYLCHOLINE; STEROL;

AMINO ACID SEQUENCE; ARTICLE; CELL MEMBRANE; CIRCULAR DICHROISM; DIFFERENTIAL SCANNING CALORIMETRY; FLUORESCENCE ANALYSIS; LIPID ANALYSIS; MOLECULAR INTERACTION; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN LIPID INTERACTION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION;

EID: 9644281567     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2004.10.064     Document Type: Article

References (47)

1. R.G. Anderson The caveolae membrane system Annu. Rev. Biochem. 67 1998 199 225
2. A.W. Cohen, T.P. Combs, P.E. Scherer, and M.P. Lisanti Role of caveolin and caveolae in insulin signaling and diabetes Am. J. Physiol. Endocrinol. Metab. 285 2003 E1151 E1160
3. B. Chini, and M. Parenti G-protein coupled receptors in lipid rafts and caveolae: how, when and why do they go there? J. Mol. Endocrinol. 32 2004 325 338
4. C.J. Fielding, and P.E. Fielding Relationship between cholesterol trafficking and signaling in rafts and caveolae Biochim. Biophys. Acta 1610 2003 219 228
5. P. Liu, Y. Ying, Y. Zhao, D.I. Mundy, M. Zhu, and R.G. Anderson Chinese hamster ovary K2 cell lipid droplets appear to be metabolic organelles involved in membrane traffic J. Biol. Chem. 279 2004 3787 3792
6. B. Razani, S.E. Woodman, and M.P. Lisanti Caveolae: from cell biology to animal physiology Pharmacol. Rev. 54 2002 431 467
7. B. Razani, and M.P. Lisanti Caveolin-deficient mice: insights into caveolar function human disease J. Clin. Invest. 108 2001 1553 1561
8. E.J. Smart, G.A. Graf, M.A. McNiven, W.C. Sessa, J.A. Engelman, and P.E. Scherer Caveolins, liquid-ordered domains, and signal transduction Mol. Cell Biol. 19 1999 7289 7304
9. J.P. Gratton, P. Bernatchez, and W.C. Sessa Caveolae and caveolins in the cardiovascular system Circ. Res. 94 2004 1408 1417
10. P.G. Frank, S.E. Woodman, D.S. Park, and M.P. Lisanti Caveolin, caveolae, and endothelial cell function Arterioscler. Thromb. Vasc. Biol. 23 2003 1161 1168
11. R. Hnasko, and M.P. Lisanti The biology of caveolae: lessons from caveolin knockout mice and implications for human disease Mol. Interv. 3 2003 445 464
12. S.B. Gaudreault, D. Dea, and J. Poirier Increased caveoliN-1 expression in Alzheimer's disease brain Neurobiol. Aging 25 2004 753 759
13. K. Simons, and R. Ehehalt Cholesterol, lipid rafts, and disease J. Clin. Invest. 110 2002 597 603
14. T. Okamoto, A. Schlegel, P.E. Scherer, and M.P. Lisanti Caveolins, a family of scaffolding proteins for organizing "preassembled signaling complexes" at the plasma membrane J. Biol. Chem. 273 1998 5419 5422
15. T.M. Williams, and M.P. Lisanti The caveolin proteins Genome Biol. 5 2004 214
16. S. Li, K.S. Song, and M.P. Lisanti Expression and characterization of recombinant caveolin. Purification by polyhistidine tagging and cholesterol-dependent incorporation into defined lipid membranes J. Biol. Chem. 271 1996 568 573
17. Y. Fu, A. Hoang, G. Escher, R.G. Parton, Z. Krozowski, and D. Sviridov Expression of caveolin-1 enhances cholesterol efflux in hepatic cells J. Biol. Chem. 279 2004 14140 14146
18. M.J. Robenek, N.J. Severs, K. Schlattmann, G. Plenz, K.P. Zimmer, D. Troyer, and H. Robenek Lipids partition caveolin-1 from ER membranes into lipid droplets: updating the model of lipid droplet biogenesis FASEB J. 18 2004 866 868
19. P. Sens, and M.S. Turner Theoretical model for the formation of caveolae and similar membrane invaginations Biophys. J. 86 2004 2049 2057
20. B. Razani, J.A. Engelman, X.B. Wang, W. Schubert, X.L. Zhang, and C.B. Marks Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities J. Biol. Chem. 276 2001 38121 38138
21. M. Drab, P. Verkade, M. Elger, M. Kasper, M. Lohn, and B. Lauterbach Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice Science 293 2001 2449 2452
22. R. Ross The pathogenesis of atherosclerosis: a perspective for the 1990s Nature 362 1993 801 809
23. G.S. Hassan, J.F. Jasmin, W. Schubert, P.G. Frank, and M.P. Lisanti Caveolin-1 deficiency stimulates neointima formation during vascular injury Biochemistry 43 2004 8312 8321
24. K.A. Cho, S.J. Ryu, Y.S. Oh, J.H. Park, J.W. Lee, and H.P. Kim Morphological adjustment of senescent cells by modulating caveolin-1 status J. Biol. Chem. 279 2004 42270 42278
25. E.J. Smart, and R.G. Anderson Alterations in membrane cholesterol that affect structure and function of caveolae Methods Enzymol. 353 2002 131 139
26. U. Ortegren, M. Karlsson, N. Blazic, M. Blomqvist, F.H. Nystrom, and J. Gustavsson Lipids and glycosphingolipids in caveolae and surrounding plasma membrane of primary rat adipocytes Eur. J. Biochem. 271 2004 2028 2036
27. A. Hinderliter, R.L. Biltonen, and P.F. Almeida Lipid modulation of protein-induced membrane domains as a mechanism for controlling signal transduction Biochemistry 43 2004 7102 7110
28. K.G. Rothberg, J.E. Heuser, W.C. Donzell, Y.S. Ying, J.R. Glenney, and R.G. Anderson Caveolin, a protein component of caveolae membrane coats Cell 68 1992 673 682
29. M. Sargiacomo, P.E. Scherer, Z. Tang, E. Kubler, K.S. Song, M.C. Sanders, and M.P. Lisanti Oligomeric structure of caveolin: implications for caveolae membrane organization Proc. Natl Acad. Sci. USA 92 1995 9407 9411
30. D.A. Brown, and E. London Structure and function of sphingolipid- and cholesterol-rich membrane rafts J. Biol. Chem. 275 2000 17221 17224
31. D.J. Dietzen, W.R. Hastings, and D.M. Lublin Caveolin is palmitoylated on multiple cysteine residues. Palmitoylation is not necessary for localization of caveolin to caveolae J. Biol. Chem. 270 1995 6838 6842
32. A. Uittenbogaard, and E.J. Smart Palmitoylation of caveolin-1 is required for cholesterol binding, chaperone complex formation, and rapid transport of cholesterol to caveolae J. Biol. Chem. 275 2000 25595 25599
33. A. Schlegel, R.B. Schwab, P.E. Scherer, and M.P. Lisanti A role for the caveolin scaffolding domain in mediating the membrane attachment of caveolin-1. The caveolin scaffolding domain is both necessary and sufficient for membrane binding in vitro J. Biol. Chem. 274 1999 22660 22667
34. S.P. Wanaski, B.K. Ng, and M. Glaser Caveolin scaffolding region and the membrane binding region of SRC form lateral membrane domains Biochemistry 42 2003 42 56
35. H. Li, and V. Papadopoulos Peripheral-type benzodiazepine receptor function in cholesterol transport. Identification of a putative cholesterol recognition/interaction amino acid sequence and consensus pattern Endocrinology 139 1998 4991 4997
36. H. Li, Z. Yao, B. Degenhardt, G. Teper, and V. Papadopoulos Cholesterol binding at the cholesterol recognition/interaction amino acid consensus (CRAC) of the peripheral-type benzodiazepine receptor and inhibition of steroidogenesis by an HIV TAT-CRAC peptide Proc. Natl Acad. Sci. USA 98 2001 1267 1272
37. S.E. Woodman, A. Schlegel, A.W. Cohen, and M.P. Lisanti Mutational analysis identifies a short atypical membrane attachment sequence (KYWFYR) within caveolin-1 Biochemistry 41 2002 3790 3795
38. R.M. Epand, B.G. Sayer, and R.F. Epand Peptide-induced formation of cholesterol-rich domains Biochemistry 42 2003 14677 14689
39. A. Arbuzova, L. Wang, J. Wang, G. Hangyas-Mihalyne, D. Murray, B. Honig, and S. McLaughlin Membrane binding of peptides containing both basic and aromatic residues. Experimental studies with peptides corresponding to the scaffolding region of caveolin and the effector region of MARCKS Biochemistry 39 2000 10330 10339
40. R.M. Epand Do proteins facilitate the formation of cholesterol-rich domains? Biochim. Biophys. Acta: Bio-Membr. 1666 2004 227 238
41. J. Forbes, J. Bowers, X. Shan, L. Moran, E. Oldfield, and M.A. Moscarello Some new developments in solid-state nuclear magnetic resonance spectroscopy studies of lipids and biological membranes, including the effects of cholesterol in model and natural systems J. Chem. Soc., Faraday Trans. 84 1988 3821 3849
42. M.R. Arnold, W. Kremer, H.D. Ludemann, and H.R. Kalbitzer 1H-NMR parameters of common amino acid residues measured in aqueous solutions of the linear tetrapeptides Gly-Gly-X-Ala at pressures between 0.1 and 200 MPa Biophys. Chem. 96 2002 129 140
43. H.A. Sober Numerical values of the absorbances of the aromatic amino acids H.A. Sober Handbook of Biochemistry: Selected Data for Molecular Biology 1970 The Chemical Rubber Co. Cleveland, OH 75 76
44. G. Privalov, V. Kavina, E. Freire, and P.L. Privalov Precise scanning calorimeter for studying thermal properties of biological macromolecules in dilute solution Anal. Biochem. 232 1995 79 85
45. B.N. Ames Assay of inorganic phosphate, total phosphate and phosphatases Methods Enzymol. 8 1966 115 118
46. N. Sreerama, S.Y. Venyaminov, and R.W. Woody Estimation of the number of alpha-helical and beta-strand segments in proteins using circular dichroism spectroscopy Protein Sci. 8 1999 370 380
47. W. Guo, and J.A. Hamilton 13C MAS NMR studies of crystalline cholesterol and lipid mixtures modeling atherosclerotic plaques Biophys. J. 71 1996 2857 2868